公开(公告)号：US07649003B2

公开(公告)日：2010-01-19

申请号：US11928513

申请日：2007-10-30

Applicant: Alan Daniel Brown ,  David Ellis ,  Christopher Ronald Smith

Inventor： Alan Daniel Brown ,  David Ellis ,  Christopher Ronald Smith

IPC: A61K31/4439 ,  C07D401/14

CPC classification number: C07D249/08 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04

Abstract: The present invention relates to a class of substituted 1,2,4-triazoles of formula (1) with activity as oxytocin antagonists, uses thereof, processes for the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction, particularly premature ejaculation (P.E.).

Abstract translation: 本发明涉及一类具有作为催产素拮抗剂的活性的式（1）的取代的1,2,4-三唑，其用途，其制备方法和含有所述抑制剂的组合物。 这些抑制剂可用于各种治疗领域，包括性功能障碍，特别是早泄（P.E.）。

公开(公告)号：US07613719B2

公开(公告)日：2009-11-03

申请号：US10804815

申请日：2004-03-18

Applicant: Su Chin Chang ,  Ravi Shahani ,  Michael Calcagno ,  Robert Stumberger ,  Nicholas Caldwell ,  Allan Folting ,  Charles David Ellis

Inventor： Su Chin Chang ,  Ravi Shahani ,  Michael Calcagno ,  Robert Stumberger ,  Nicholas Caldwell ,  Allan Folting ,  Charles David Ellis

IPC: G06F7/00 ,  G06F17/30 ,  G06F17/00 ,  G06F17/27

CPC classification number: G06F17/30401 ,  Y10S707/99933 ,  Y10S707/99943

Abstract: The present invention relates to a method of manipulating a software application and processing data stored in a data source. The method includes receiving a natural language input and analyze the natural language input to identify semantic information contained therein. Portions of the natural language input are associated with command objects and entity objects of a schema based on the semantic information and the natural language input. The method also includes rendering data from the data source in a table of columns and rows based on the schema and the associated portions of the natural language input.

Abstract translation: 本发明涉及一种操纵软件应用程序和处理存储在数据源中的数据的方法。 该方法包括接收自然语言输入并分析自然语言输入以识别其中包含的语义信息。 基于语义信息和自然语言输入，自然语言输入的部分与模式的命令对象和实体对象相关联。 该方法还包括基于自然语言输入的模式和相关联的部分在列和行的表中呈现来自数据源的数据。

公开(公告)号：US07451397B2

公开(公告)日：2008-11-11

申请号：US11012964

申请日：2004-12-15

Applicant: Brandon G. Weber ,  Charles David Ellis

Inventor： Brandon G. Weber ,  Charles David Ellis

IPC: G06F17/00

CPC classification number: G06F17/276 ,  G06F17/246

Abstract: A system and method for automatically completing a formula of a spreadsheet application, calculator application, accounting application, business application or banking application. One aspect of the present invention is a computer-implemented method for automatically completing formulaic cell data. The computer-implemented method includes a step for substantiating an autocomplete process in response to a user input of formulaic cell data and aggregating autocomplete options based on the user input. Another aspect of the present invention includes displaying a dynamic list of autocomplete options when the user input is a trigger.

Abstract translation: 一种用于自动完成电子表格应用程序，计算器应用程序，会计应用程序，业务应用程序或银行应用程序的公式的系统和方法。 本发明的一个方面是用于自动完成配方单元数据的计算机实现的方法。 计算机实现的方法包括响应于用户输入公式信元数据并且基于用户输入聚合自动完成选项来证实自动完成过程的步骤。 本发明的另一方面包括当用户输入是触发时显示自动完成选项的动态列表。

公开(公告)号：US20080026118A1

公开(公告)日：2008-01-31

申请号：US11686027

申请日：2007-03-14

Applicant: John Richard Bows ,  Colin Jeffrey Burnham ,  Jonathan Paul Coker ,  David Lester Hickie ,  Greg Paul Hilliard ,  Michelle Louise Lock ,  Norman John Maloney ,  Brian Richard Newberry ,  Paul Frederick Tomlinson ,  David Ellis ,  Martin Yonnone ,  Stanley Joseph Whitehair

Inventor： John Richard Bows ,  Colin Jeffrey Burnham ,  Jonathan Paul Coker ,  David Lester Hickie ,  Greg Paul Hilliard ,  Michelle Louise Lock ,  Norman John Maloney ,  Brian Richard Newberry ,  Paul Frederick Tomlinson ,  David Ellis ,  Martin Yonnone ,  Stanley Joseph Whitehair

IPC: A23L1/025 ,  A21D10/00 ,  A21D13/04 ,  A23L1/212 ,  A23L1/36 ,  B65B25/00 ,  G01N33/00 ,  C11B1/00 ,  A47J27/00 ,  A23L1/216 ,  A23L1/20 ,  A23L1/01

CPC classification number: A23L19/18 ,  A23L5/15 ,  A23L7/117 ,  A23L19/09

Abstract: The present invention is directed towards a method for making a healthy snack food having an appearance and taste similar to conventional fried snack products without the use of an oil-frying process. The method of the present invention includes the steps of providing food slices from a starch-based food or dough. The food slices can be blanched and a controlled amount of oil can be added to enhance final organoleptical properties. The food slices are then rapidly dehydrated to a much lower moisture content in a primary drying step that simulates conventional frying dehydration rates. A food snack, such as a corn or potato-based snack, produced by this method is a low-fat, ready-to-eat snack having the conventional texture and taste associated with fried snack products.

公开(公告)号：US20070269528A1

公开(公告)日：2007-11-22

申请号：US11831696

申请日：2007-07-31

Applicant: David Ellis ,  George Miljanich ,  David Shields

Inventor： David Ellis ,  George Miljanich ,  David Shields

IPC: A61K35/56 ,  A61P25/04

CPC classification number: A61K38/1767 ,  A61K9/0085 ,  A61K31/137 ,  A61K31/195 ,  A61K31/4168 ,  A61K31/445 ,  A61K31/4468 ,  A61K31/451 ,  A61K31/4535 ,  A61K31/485 ,  A61K38/17 ,  A61K45/06 ,  A61K47/12 ,  A61K47/183 ,  C07K14/43504 ,  A61K2300/00

Abstract: The present invention is direct to a method of producing analgesia in a mammalian subject. The method includes administering to the subject an omega conopeptide, preferably ziconotide, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyil, buprenorphine, and sufentanil, or its pharmaceutically acceptable salts thereof, wherein the ω-conopeptide retains its potency and is physically and chemically compatible with the analgesic compound. A preferred route of administration is intrathecal administration, particularly continuous intrathecal infusion. The present invention is also directed to a pharmaceutical formulation comprising an omega conopeptide, preferably ziconotide, an antioxidant, in combination with an analgesic selected from the group consisting of morphine, bupivicaine, clonidine, hydromorphone, baclofen, fentanyl, buprenorphine, and sufentanil.

Abstract translation: 本发明直接涉及在哺乳动物受试者中产生止痛的方法。 该方法包括向受试者施用欧米加多肽，优选西科肽，与选自吗啡，布比卡因，可乐定，氢吗啡酮，巴氯芬，芬太尼，丁丙诺啡和舒芬太尼的止痛剂或其药学上可接受的盐组合，其中 欧米加肽保留其效力并且与止痛化合物物理和化学相容。 优选的给药途径是鞘内给药，特别是连续鞘内输注。 本发明还涉及一种药物制剂，其包含ω-肽，优选齐考诺苷，抗氧化剂，与选自吗啡，布比卡因，可乐定，氢吗啡酮，巴氯芬，芬太尼，丁丙诺啡和舒芬太尼的止痛剂组合。

公开(公告)号：US20070186671A1

公开(公告)日：2007-08-16

申请号：US11655807

申请日：2007-01-19

Applicant: Peter Rogers ,  David Ellis ,  Pradip Sheth ,  Dominick Montie

Inventor： Peter Rogers ,  David Ellis ,  Pradip Sheth ,  Dominick Montie

IPC: G01L1/24

CPC classification number: G01N21/952 ,  G01M5/0025 ,  G01M5/0075 ,  G01R33/44

Abstract: An inspection system for removably mounting to a platform movable in relation to a generally upright mast for inspection of the mast has a mounting support assembly removably fixable to the platform. The mounting support assembly for scanning the mast carries a detector device and collecting mast scanned information. A power supply is carried by one or more of the mounting support assembly or the detector device and is connected to the detector device. A communications device is carried by one or more of the mounting support assembly or the detector device and is connected to the detector device for receiving and relaying the collected mast scanned information.

Abstract translation: 一种用于可拆卸地安装到可相对于大体直立的桅杆移动的平台的检查系统，用于检查桅杆具有可拆卸地固定到平台上的安装支撑组件。 用于扫描桅杆的安装支撑组件携带检测器装置并收集桅杆扫描信息。 电源由一个或多个安装支撑组件或检测器装置承载并连接到检测器装置。 通信设备由一个或多个安装支撑组件或检测器装置携带，并且连接到检测器装置，用于接收和中继收集的桅杆扫描信息。

公开(公告)号：US20070185078A1

公开(公告)日：2007-08-09

申请号：US11570199

申请日：2005-05-27

Applicant: Alan Brown ,  Andrew Calabrese ,  David Ellis ,  Lesa Watson

Inventor： Alan Brown ,  Andrew Calabrese ,  David Ellis ,  Lesa Watson

IPC: A61K31/551 ,  A61K31/554 ,  C07D487/12 ,  C07D498/02

CPC classification number: C07D471/14 ,  C07D487/14 ,  C07D498/04

Abstract: This invention relates to compounds of formula (I)

Abstract translation: 本发明涉及式（I）化合物，

公开(公告)号：US07184519B2

公开(公告)日：2007-02-27

申请号：US10675127

申请日：2003-09-30

Applicant: Ram Kishan Singh B ,  Bindu Santha Philip ,  Vipin J. Pillai ,  David Ellis Barker ,  Lonnie Weston

Inventor： Ram Kishan Singh B ,  Bindu Santha Philip ,  Vipin J. Pillai ,  David Ellis Barker ,  Lonnie Weston

IPC: H05G1/02

CPC classification number: A61B6/4441 ,  A61B6/4405

Abstract: A medical imaging system including an imaging device and a patient positioning area in close proximity to the imaging device. A protective bumper is attached to, and conforms to a shape of the imaging device. The system may also include a detection system that has a pressure sensing device.

Abstract translation: 一种医疗成像系统，包括成像装置和靠近成像装置的患者定位区域。 保护保险杠附接到并符合成像装置的形状。 该系统还可以包括具有压力感测装置的检测系统。

公开(公告)号：US06396604B1

公开(公告)日：2002-05-28

申请号：US09043409

申请日：1998-03-19

Applicant: Kevin Smith ,  Julian Kazimierz Lucek ,  Danny Robert Pitcher ,  Terrence Widdowson ,  David Graham Moodie ,  Andrew David Ellis

Inventor： Kevin Smith ,  Julian Kazimierz Lucek ,  Danny Robert Pitcher ,  Terrence Widdowson ,  David Graham Moodie ,  Andrew David Ellis

IPC: H04B1000

CPC classification number: H04L7/0075 ,  H01S5/4006 ,  H04B10/505 ,  H04B10/5051 ,  H04B10/508 ,  H04J14/08 ,  H04J14/083 ,  H04L7/0037 ,  H04L7/0337

Abstract: An optical network includes a number of nodes coupled to an optical transmission medium, such as an optical fiber bus. Each of the nodes includes a dark pulse generator. Different nodes output dark pulses in different time slots onto the transmission medium, forming a dark pulse OTDM (optical time division multiplexed) signal. The network may have a re-entrant bus topology.

Abstract translation: 光网络包括耦合到诸如光纤总线之类的光传输介质的多个节点。 每个节点包括暗脉冲发生器。 不同的节点将不同时隙的暗脉冲输出到传输介质上，形成暗脉冲OTDM（光时分复用）信号。 该网络可能具有重新启动的总线拓扑。

公开(公告)号：US5750520A

公开(公告)日：1998-05-12

申请号：US628642

申请日：1996-04-19

Applicant: John Christopher Danilewicz ,  David Ellis ,  Ryszard Jurek Kobylecki

Inventor： John Christopher Danilewicz ,  David Ellis ,  Ryszard Jurek Kobylecki

IPC: A61K31/47 ,  A61K31/55 ,  A61K38/00 ,  A61P7/02 ,  A61P9/08 ,  A61P9/10 ,  C07D401/12 ,  C07D401/14 ,  C07K5/065 ,  C07D217/00 ,  C07D217/16

CPC classification number: C07D401/12

Abstract: This invention relates to compounds of formula (I), ##STR1## pharmaceutically acceptable salt thereof, and pharmaceutically acceptable solvates of either entity, wherein X is CH or N; Y is optionally monousaturated C.sub.3 -C.sub.5 alkylene optionally substituted with C.sub.1 -C.sub.4 alkyl or methylene; R.sup.1 is H; C.sub.1 -C.sub.4 alkyl optionally substituted with C.sub.1 -C.sub.4 alkoxy, OH, NR.sup.5 R.sup.6, CONR.sup.5 R.sup.6, C.sub.3 -C.sub.6 cycloalkyl or aryl; or C.sub.3 -C.sub.6 alkenyl; R.sup.2 is H; C.sub.1 -C.sub.4 alkyl optionally substituted with C.sub.1 -C.sub.4 alkoxy, OH, NR.sup.5 R.sup.6, CONR.sup.5 R.sup.6, C.sub.3 -C.sub.6 cycloalkyl or aryl; or CONR.sup.5 R.sup.6 ; R.sup.3 and R.sup.4 are each independently selected from H; C.sub.1 -C.sub.4 alkyl optionally substituted with NR.sup.5 R.sup.6 ; C.sub.1 -C.sub.4 alkoxy; halo; CONR.sup.5 R.sup.6 and aryl; R.sup.5 and R.sup.6 are each independently selected from H and C.sub.1 -C.sub.4 alkyl; and m and n are each independently 1, 2 or 3; are potent and selective thrombin inhibitors useful in the treatment of, inter alia, deep vein thrombosis; reocclusion following thrombolytic therapy; chronic arterial obstruction; peripheral vascular disease; acute myocardial infarction; unstable angina; atrial fibrillation; thrombotic stroke; transient ischaemic attacks; restenosis and occlusion following angioplasty; or neurodegenerative disorders.

Abstract translation: PCT No.PCT / EP94 / 03509 Sec。 371日期：1996年04月19日 102（e）日期1996年4月19日PCT 1994年10月24日PCT公布。 出版物WO95 / 13274 日期：1995年5月18日本发明涉及式（I）的化合物，其中X是CH或N;其中X是CH或N; Y任选被C 1 -C 4烷基或亚甲基取代的单饱和C 3 -C 5亚烷基; R1是H; 任选被C 1 -C 4烷氧基，OH，NR 5 R 6，CONR 5 R 6，C 3 -C 6环烷基或芳基取代的C 1 -C 4烷基; 或C 3 -C 6烯基; R2为H; 任选被C 1 -C 4烷氧基，OH，NR 5 R 6，CONR 5 R 6，C 3 -C 6环烷基或芳基取代的C 1 -C 4烷基; 或CONR5R6; R3和R4各自独立地选自H; 任选被NR 5 R 6取代的C 1 -C 4烷基; C1-C4烷氧基; 光环; CONR5R6和芳基; R 5和R 6各自独立地选自H和C 1 -C 4烷基; m和n各自独立地为1,2或3; 是有效和选择性的凝血酶抑制剂，可用于治疗特别是深静脉血栓形成; 溶栓治疗后再闭塞; 慢性动脉阻塞; 周边血管疾病; 急性心肌梗塞; 不稳定型心绞痛; 房颤; 血栓性脑卒中 短暂性脑缺血发作; 血管成形术后再狭窄和闭塞; 或神经变性疾病。